Financials
Financial year 2025
ASK4PHARMA CONSULTING from Stekene, company number BE0744703246, closed financial year 2025 with a result of € 386,067 after tax. For that financial year ASK4PHARMA CONSULTING recorded a gross margin of € 479,328 and equity of € 1.5 million. Compared with financial year 2024, the result moved from € 302,902 to € 386,067. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ 1.5 million
▲ 32% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 386,067
▲ 27% vs 2024
Profit after tax over the fiscal year.
€ 90,571
▲ 10% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 26,311 paid out
7 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 31,164
▲ 48% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 5,707
▲ 148% vs 2024
Loans from banks and other lenders, long and short.
€ 3
▼ € 3,096 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 27,692
▼ 36% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 350,676 | € 405,737 | € 445,002 | € 479,328 | ▲ 8% |
| Profit after taxes | € 231,842 | € 283,758 | € 302,902 | € 386,067 | ▲ 27% |
| Equity | € 547,501 | € 831,259 | € 1,134,161 | € 1,493,917 | ▲ 32% |
| Total debts | € 122,664 | € 90,277 | € 103,547 | € 116,969 | ▲ 13% |
| Cash | € 312,233 | € 130,539 | € 82,058 | € 90,571 | ▲ 10% |
| Land & buildings | € 5,396 | € 4,979 | € 4,562 | € 4,145 | ▼ 9% |
| Retained profit | € 546,501 | € 830,259 | € 1,133,161 | € 1,492,917 | ▲ 32% |
| Dividend | € 0 | € 0 | € 0 | € 26,311 | |
| Bank debt | € 2,325 | € 856 | € 2,303 | € 5,707 | ▲ 148% |
| Balance sheet total | € 670,165 | € 921,536 | € 1,237,708 | € 1,610,886 | ▲ 30% |
Key figures of ASK4PHARMA CONSULTING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ASK4PHARMA CONSULTING?
What happened at ASK4PHARMA CONSULTING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 386,067 (▲ 27% vs 2024). filed late Source: NBB ↗
- New establishment in Stekene. KBO
- Start of the company according to the CBE. KBO
- Ann Smet became a director. NBB
- Koenraad Strobbe became a director. NBB
In short
From € 231,842 profit in 2022 to € 386,067 profit in 2025.
Paid € 498,227 in corporate taxes since 2022.
Best year ever: 2025, with € 386,067 profit.
Paid out € 26,311 in dividends to the owners in total.
A new publication or filing at ASK4PHARMA CONSULTING? We notify you, reason included.
Follow ASK4PHARMA CONSULTINGDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ASK4PHARMA CONSULTING are Ann Smet and Koenraad Strobbe.
Directors
According to the 2025 annual accounts
Ann Smet
Director
since 2020
Koenraad Strobbe
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Brugstraat(STE) 65
9190 Stekene
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0744.703.246
- VAT number
- BE 0744.703.246
- Registered office
- Brugstraat(STE) 65, 9190 Stekene
- Names & denominations
- ASK4PHARMA CONSULTING
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 March 2020
- Peppol
- Active · Active since 30 Sept 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg